InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Smith Mark Douglas, Director. Insider active across 3 companies, notably Teladoc Health, Inc.. Cumulatively, 9 disclosures have been logged. Total volume traded: €89k. The latest transaction was disclosed on 2 December 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
819 shares
Common Stock
SEC:0001415889-22-005235:0·
€44,686417 shares@ €107.16010.0003% mcap100.0% of flow
Ordinary Shares
SEC:0001765581-21-000133·
€44,686417 shares@ €107.16010.0003% mcap50.0% of flow
Ordinary Shares
SEC:0001765581-21-000133:0·
02,246 shares0
Ordinary Shares
SEC:0001765581-21-000083·
02,246 shares0
Ordinary Shares
SEC:0001765581-21-000083:0·
02,605 shares0
Common Stock
SEC:0001562180-21-004894·
02,605 shares0
Common Stock
SEC:0001562180-21-004894:0·
524 shares
Common Stock
SEC:0001179110-21-005495·
524 shares
Common Stock
SEC:0001179110-21-005495:0·
9 of 9 declarations
About Smith Mark Douglas
Mark Douglas Smith is a Director at Teladoc Health, Inc., Phreesia, Inc., and Jazz Pharmaceuticals plc. In these roles, he contributes to the governance and strategy of the companies. His expertise in the healthcare and biotechnology sectors is essential for their development.
